
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14464749
[patent_doc_number] => 20190184014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => Long-Lived Gadolinium Based Tumor Targeting Imaging and Therapy Agents
[patent_app_type] => utility
[patent_app_number] => 16/285358
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/285358 | Long-lived gadolinium based tumor targeting imaging and therapy agents | Feb 25, 2019 | Issued |
Array
(
[id] => 16569226
[patent_doc_number] => 20210008232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/969673
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969673
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969673 | Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer | Feb 21, 2019 | Issued |
Array
(
[id] => 14435787
[patent_doc_number] => 20190175765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/279479
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279479
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279479 | Methods for treating and diagnosing blinding eye diseases | Feb 18, 2019 | Issued |
Array
(
[id] => 18762961
[patent_doc_number] => 11813340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy
[patent_app_type] => utility
[patent_app_number] => 16/967488
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 20089
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967488 | PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy | Feb 5, 2019 | Issued |
Array
(
[id] => 14306547
[patent_doc_number] => 20190142977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => GADOLINIUM-BASED CONTRAST AGENTS FOR SENSITIVE DETECTION OF Zn2+ WITH MRI
[patent_app_type] => utility
[patent_app_number] => 16/246890
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -81
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246890
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246890 | Gadolinium-based contrast agents for sensitive detection of Zn | Jan 13, 2019 | Issued |
Array
(
[id] => 14537419
[patent_doc_number] => 20190204331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => REAL-TIME IMAGING SENSOR FOR MEASURING CELLULAR THIOL LEVEL
[patent_app_type] => utility
[patent_app_number] => 16/238371
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16238371
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/238371 | Real-time imaging sensor for measuring cellular thiol level | Jan 1, 2019 | Issued |
Array
(
[id] => 16389682
[patent_doc_number] => 20200330623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => MULTINUCLEAR COMPLEXES AND THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/957000
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957000 | MULTINUCLEAR COMPLEXES AND THEIR PREPARATION | Dec 20, 2018 | Abandoned |
Array
(
[id] => 19106821
[patent_doc_number] => 11959913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Quantitative cellular method for determining the biological activity of an anti-CD26 ligand
[patent_app_type] => utility
[patent_app_number] => 16/768206
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 8694
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768206
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768206 | Quantitative cellular method for determining the biological activity of an anti-CD26 ligand | Dec 20, 2018 | Issued |
Array
(
[id] => 16609110
[patent_doc_number] => 10910123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Methods and devices for isolating lead 203
[patent_app_type] => utility
[patent_app_number] => 16/228637
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5267
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228637
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228637 | Methods and devices for isolating lead 203 | Dec 19, 2018 | Issued |
Array
(
[id] => 16663924
[patent_doc_number] => 10933146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Cell-permeable imaging sensors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/218155
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 26
[patent_no_of_words] => 13716
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16218155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/218155 | Cell-permeable imaging sensors and uses thereof | Dec 11, 2018 | Issued |
Array
(
[id] => 16459563
[patent_doc_number] => 10842891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Imaging histone deacetylases with a radiotracer using positron emission tomography
[patent_app_type] => utility
[patent_app_number] => 16/213358
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 14
[patent_no_of_words] => 11566
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16213358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/213358 | Imaging histone deacetylases with a radiotracer using positron emission tomography | Dec 6, 2018 | Issued |
Array
(
[id] => 18717725
[patent_doc_number] => 11795056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Method for producing astatine
[patent_app_type] => utility
[patent_app_number] => 16/770403
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2612
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770403 | Method for producing astatine | Dec 6, 2018 | Issued |
Array
(
[id] => 14130231
[patent_doc_number] => 20190099505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => COATED UP-CONVERSION NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/212346
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212346
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212346 | COATED UP-CONVERSION NANOPARTICLES | Dec 5, 2018 | Abandoned |
Array
(
[id] => 16504868
[patent_doc_number] => 20200384124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => VECTOR FOR PHARMACOLOGICALLY ACTIVE MATER-INSOLUBLE MOLECULES, AND PROCESS OF PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/770373
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770373 | VECTOR FOR PHARMACOLOGICALLY ACTIVE MATER-INSOLUBLE MOLECULES, AND PROCESS OF PREPARING SAME | Dec 4, 2018 | Abandoned |
Array
(
[id] => 15664139
[patent_doc_number] => 10596277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => High purity therapeutic bone agents
[patent_app_type] => utility
[patent_app_number] => 16/194324
[patent_app_country] => US
[patent_app_date] => 2018-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2700
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16194324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/194324 | High purity therapeutic bone agents | Nov 16, 2018 | Issued |
Array
(
[id] => 16197463
[patent_doc_number] => 10722601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Gadolinium chelate compounds for use in magnetic resonance imaging
[patent_app_type] => utility
[patent_app_number] => 16/192185
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 24725
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16192185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/192185 | Gadolinium chelate compounds for use in magnetic resonance imaging | Nov 14, 2018 | Issued |
Array
(
[id] => 17889839
[patent_doc_number] => 11452786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Double-labeled probe for molecular imaging and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/763667
[patent_app_country] => US
[patent_app_date] => 2018-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17954
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 483
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763667
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763667 | Double-labeled probe for molecular imaging and use thereof | Nov 11, 2018 | Issued |
Array
(
[id] => 16310940
[patent_doc_number] => 20200289678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => COMPOSITION, COMPOSITION FOR DYNAMIC NUCLEAR POLARIZATION, POLARIZATION ENHANCING METHOD, HIGHLY POLARIZED SUBSTANCE, AND NMR MEASUREMENT METHOD
[patent_app_type] => utility
[patent_app_number] => 16/759522
[patent_app_country] => US
[patent_app_date] => 2018-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/759522 | COMPOSITION, COMPOSITION FOR DYNAMIC NUCLEAR POLARIZATION, POLARIZATION ENHANCING METHOD, HIGHLY POLARIZED SUBSTANCE, AND NMR MEASUREMENT METHOD | Oct 24, 2018 | Abandoned |
Array
(
[id] => 16341727
[patent_doc_number] => 20200306377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHODS FOR ENHANCING 5-AMINOLEVULINIC ACID-BASED MEDICAL IMAGING AND PHOTOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/754625
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754625
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754625 | METHODS FOR ENHANCING 5-AMINOLEVULINIC ACID-BASED MEDICAL IMAGING AND PHOTOTHERAPY | Oct 17, 2018 | Abandoned |
Array
(
[id] => 17967103
[patent_doc_number] => 11484608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)
[patent_app_type] => utility
[patent_app_number] => 16/652892
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 164
[patent_figures_cnt] => 353
[patent_no_of_words] => 33434
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652892 | Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA) | Oct 4, 2018 | Issued |